Angela Dwyer is an award-winning, media measurement expert who helps brand improve business results through data-driven, actionable insights.
In this edition of our pharma newsletter, we explore advancements transforming the healthcare and pharmaceutical landscape. From government initiatives aimed at improving drug affordability and accessibility to technological innovations revolutionizing medical research and patient care, the sector is undergoing rapid changes. These developments provoke a wide range of reactions, from optimism to ethical debates, highlighting […]
This month’s top news in the pharmaceutical industry sees a shift toward both innovative breakthroughs and enhanced regulatory frameworks. The financial fallout from the Change Healthcare cyberattack exposed critical vulnerabilities in healthcare cybersecurity, prompting a broad reassessment of data protection strategies within the industry. A substantial investment in AI by Goldman Sachs highlights an increasing […]
This month’s healthcare landscape is characterized by significant regulatory and technological milestones, showing a vibrant mix of challenges and advances in medical science and patient care. Advances in AI, like healthcare assistants and drug trials, lead the way, driven by big players such as AstraZeneca, Merck, Novo Nordisk, and Pfizer. These developments, together with key […]
In this edition of our pharma newsletter, we dive into a series of groundbreaking developments reshaping the landscape of healthcare and technology. With government actions poised to enhance drug affordability and accessibility and technological innovations pushing the boundaries of medical research and patient interaction, the healthcare sector is experiencing rapid advancements. These shifts elicit a […]
The JP Morgan (JPM) Healthcare Conference is a premier annual event in the healthcare industry, bringing together global industry leaders, emerging fast-growth companies, innovative technology creators, and members of the investment community. This conference serves as a platform for companies to present their latest developments, discuss challenges and opportunities in the healthcare sector, and explore […]
The Evolving World of Healthcare and Tech Sparks Ongoing Media Interest This month’s highlights in healthcare and technology showcase a significant shift toward innovative and regulatory dynamics. Government initiatives are reshaping healthcare affordability and access, while technological breakthroughs are redefining medical research and patient care. These developments spark different reactions from various stakeholders, ranging from […]
What’s the best way to get a busy healthcare reporter’s attention? What topics are of most interest to biopharma journalists in 2024? What’s the best way to pitch your biotech story? Answers to these questions – and more – were on offer at a recent panel discussion featuring a trio of healthcare and biotechnology journalists. […]
The Role of AI and Technology in Modern Medicine Continue to Drive Media Coverage In the ever-evolving intersection of technology and healthcare, key themes regularly focus on groundbreaking advancements, regulatory challenges, and ethical dilemmas associated with artificial intelligence (AI) in medical applications. These stories not only showcase efforts to enhance human health and capabilities through […]
Tech-Driven Healthcare Advancements Steal the Media Spotlight Cutting-edge technology, particularly artificial intelligence, is revolutionizing various aspects of our lives, with healthcare standing out as a notable example. These innovations are poised to enhance capabilities, streamline processes, and tackle enduring challenges, promising to optimize traditional methods, boost efficiency, and unlock new horizons in treatment and understanding. […]
Drug pricing in the United States is a complex, multifaceted issue that significantly impacts both pharmaceutical companies and consumers. The cost of prescription medications can impact the profitability of pharmaceutical firms, potentially influencing their capacity to innovate. Concurrently, it imposes a substantial burden on consumers, sometimes compelling them to make difficult choices between essential medications […]
